Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
about
Utilization and control of ecological interactions in polymicrobial infections and community-based microbial cell factoriesPseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection.Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates.Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.Fermentation products in the cystic fibrosis airways induce aggregation and dormancy-associated expression profiles in a CF clinical isolate of Pseudomonas aeruginosa.Rhamnolipids from disperse the biofilms of sulfate-reducing bacteria
P2860
Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@ast
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@en
type
label
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@ast
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@en
prefLabel
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@ast
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@en
P2093
P2860
P356
P1476
Tobramycin-Treated Pseudomonas ...... Cystic Fibrosis Model System.
@en
P2093
Amanda A Naimie
Charles Bay
Edward F Griffin
George A O'Toole
Katherine E Price
P2860
P304
P356
10.1128/JB.00705-15
P407
P577
2015-10-19T00:00:00Z